25 XP   0   0   10

OUTLOOK THERAPEUTICS INC
Buy, Hold or Sell?

Let's analyse OUTLOOK THERAPEUTICS INC together

PenkeI guess you are interested in OUTLOOK THERAPEUTICS INC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of OUTLOOK THERAPEUTICS INC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about OUTLOOK THERAPEUTICS INC

I send you an email if I find something interesting about OUTLOOK THERAPEUTICS INC.

Quick analysis of OUTLOOK THERAPEUTICS INC (30 sec.)










What can you expect buying and holding a share of OUTLOOK THERAPEUTICS INC? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
15.8%

What is your share worth?

Current worth
$-1.13
Expected worth in 1 year
$-2.99
How sure are you?
36.8%

+ What do you gain per year?

Total Gains per Share
$-1.86
Return On Investment
-22.7%

For what price can you sell your share?

Current Price per Share
$8.17
Expected price per share
$5.0401 - $13.32
How sure are you?
50%

1. Valuation of OUTLOOK THERAPEUTICS INC (5 min.)




Live pricePrice per Share (EOD)

$8.17

Intrinsic Value Per Share

$-30.83 - $-36.69

Total Value Per Share

$-31.96 - $-37.82

2. Growth of OUTLOOK THERAPEUTICS INC (5 min.)




Is OUTLOOK THERAPEUTICS INC growing?

Current yearPrevious yearGrowGrow %
How rich?-$24.3m$20.1m-$28.5m-338.3%

How much money is OUTLOOK THERAPEUTICS INC making?

Current yearPrevious yearGrowGrow %
Making money-$12.8m-$18.3m$5.4m42.2%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of OUTLOOK THERAPEUTICS INC (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#975 / 1016

Most Revenue
#746 / 1016

Most Profit
#601 / 1016

Most Efficient
#190 / 1016

What can you expect buying and holding a share of OUTLOOK THERAPEUTICS INC? (5 min.)

Welcome investor! OUTLOOK THERAPEUTICS INC's management wants to use your money to grow the business. In return you get a share of OUTLOOK THERAPEUTICS INC.

What can you expect buying and holding a share of OUTLOOK THERAPEUTICS INC?

First you should know what it really means to hold a share of OUTLOOK THERAPEUTICS INC. And how you can make/lose money.

Speculation

The Price per Share of OUTLOOK THERAPEUTICS INC is $8.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of OUTLOOK THERAPEUTICS INC.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in OUTLOOK THERAPEUTICS INC, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-1.13. Based on the TTM, the Book Value Change Per Share is $-0.46 per quarter. Based on the YOY, the Book Value Change Per Share is $0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of OUTLOOK THERAPEUTICS INC.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.52-6.3%-0.60-7.3%-0.28-3.4%-0.31-3.7%-0.55-6.7%
Usd Book Value Change Per Share-0.46-5.6%-0.46-5.7%0.121.4%-0.01-0.1%-0.03-0.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%1,414.4317,312.4%1,477.5618,085.1%
Usd Total Gains Per Share-0.46-5.6%-0.46-5.7%0.121.4%1,414.4217,312.4%1,477.5318,084.8%
Usd Price Per Share0.39-0.86-1.28-1.61-1.38-
Price to Earnings Ratio-0.19--0.41--3.24--3.14--1.86-
Price-to-Total Gains Ratio-0.86--2.05--13.88--8.18--7.01-
Price to Book Ratio-0.35--1.32-13.28-7.67-4.41-
Price-to-Total Gains Ratio-0.86--2.05--13.88--8.18--7.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.17
Number of shares122
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.001,414.43
Usd Book Value Change Per Share-0.46-0.01
Usd Total Gains Per Share-0.461,414.42
Gains per Quarter (122 shares)-56.67172,559.16
Gains per Year (122 shares)-226.67690,236.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-227-237690240-3690227
20-453-4641380480-61380464
30-680-6912070720-102070701
40-907-9182760960-132760938
50-1133-11453451199-163451175
60-1360-13724141439-194141412
70-1587-15994831679-234831649
80-1813-18265521919-265521886
90-2040-20536212159-296212123
100-2267-22806902399-326902360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.038.00.00.0%0.038.00.00.0%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%6.014.00.030.0%10.025.03.026.3%10.025.03.026.3%
Dividend per Share1.00.03.025.0%1.00.011.08.3%4.00.016.020.0%6.00.032.015.8%6.00.032.015.8%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%9.011.00.045.0%14.021.03.036.8%14.021.03.036.8%

Fundamentals of OUTLOOK THERAPEUTICS INC

About OUTLOOK THERAPEUTICS INC

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with BioLexis Pte. Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Fundamental data was last updated by Penke on 2024-04-11 17:14:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of OUTLOOK THERAPEUTICS INC.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit OUTLOOK THERAPEUTICS INC earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare OUTLOOK THERAPEUTICS INC to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of OUTLOOK THERAPEUTICS INC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-140.8%+140.8%
5Y-140.8%10Y-914.4%+773.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y-140.8%-438.4%+297.6%
10Y-914.4%-605.5%-308.9%
1.1.2. Return on Assets

Shows how efficient OUTLOOK THERAPEUTICS INC is using its assets to generate profit.

  • Above 5% is considered healthy but always compare OUTLOOK THERAPEUTICS INC to the Biotechnology industry mean.
  • -51.5% Return on Assets means that OUTLOOK THERAPEUTICS INC generated $-0.52 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of OUTLOOK THERAPEUTICS INC:

  • The MRQ is -51.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -37.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-51.5%TTM-37.6%-13.9%
TTM-37.6%YOY-39.8%+2.2%
TTM-37.6%5Y-48.2%+10.5%
5Y-48.2%10Y-53.5%+5.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-51.5%-13.5%-38.0%
TTM-37.6%-12.9%-24.7%
YOY-39.8%-11.8%-28.0%
5Y-48.2%-14.1%-34.1%
10Y-53.5%-16.0%-37.5%
1.1.3. Return on Equity

Shows how efficient OUTLOOK THERAPEUTICS INC is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare OUTLOOK THERAPEUTICS INC to the Biotechnology industry mean.
  • 0.0% Return on Equity means OUTLOOK THERAPEUTICS INC generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of OUTLOOK THERAPEUTICS INC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-15.9%+15.9%
TTM-15.9%YOY-110.9%+95.0%
TTM-15.9%5Y-68.3%+52.4%
5Y-68.3%10Y-73.5%+5.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM-15.9%-16.1%+0.2%
YOY-110.9%-15.1%-95.8%
5Y-68.3%-19.9%-48.4%
10Y-73.5%-20.9%-52.6%

1.2. Operating Efficiency of OUTLOOK THERAPEUTICS INC.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient OUTLOOK THERAPEUTICS INC is operating .

  • Measures how much profit OUTLOOK THERAPEUTICS INC makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare OUTLOOK THERAPEUTICS INC to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of OUTLOOK THERAPEUTICS INC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-123.2%+123.2%
5Y-123.2%10Y-902.5%+779.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y-123.2%-477.4%+354.2%
10Y-902.5%-625.6%-276.9%
1.2.2. Operating Ratio

Measures how efficient OUTLOOK THERAPEUTICS INC is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of OUTLOOK THERAPEUTICS INC:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y2.267-2.267
5Y2.26710Y18.058-15.791
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y2.2675.679-3.412
10Y18.0587.894+10.164

1.3. Liquidity of OUTLOOK THERAPEUTICS INC.

1.3. Liquidity
1.3.1. Current Ratio

Measures if OUTLOOK THERAPEUTICS INC is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.44 means the company has $0.44 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of OUTLOOK THERAPEUTICS INC:

  • The MRQ is 0.444. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.797. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.444TTM0.797-0.353
TTM0.797YOY2.410-1.613
TTM0.7975Y1.446-0.649
5Y1.44610Y0.848+0.598
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4443.914-3.470
TTM0.7974.220-3.423
YOY2.4105.388-2.978
5Y1.4466.045-4.599
10Y0.8486.406-5.558
1.3.2. Quick Ratio

Measures if OUTLOOK THERAPEUTICS INC is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare OUTLOOK THERAPEUTICS INC to the Biotechnology industry mean.
  • A Quick Ratio of 0.23 means the company can pay off $0.23 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of OUTLOOK THERAPEUTICS INC:

  • The MRQ is 0.225. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.601. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.225TTM0.601-0.376
TTM0.601YOY1.906-1.305
TTM0.6015Y1.110-0.510
5Y1.11010Y0.656+0.455
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2253.572-3.347
TTM0.6013.998-3.397
YOY1.9065.390-3.484
5Y1.1105.969-4.859
10Y0.6566.287-5.631

1.4. Solvency of OUTLOOK THERAPEUTICS INC.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of OUTLOOK THERAPEUTICS INC assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare OUTLOOK THERAPEUTICS INC to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.12 means that OUTLOOK THERAPEUTICS INC assets are financed with 212.3% credit (debt) and the remaining percentage (100% - 212.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of OUTLOOK THERAPEUTICS INC:

  • The MRQ is 2.123. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.375. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.123TTM1.375+0.748
TTM1.375YOY0.598+0.777
TTM1.3755Y1.269+0.106
5Y1.26910Y1.651-0.382
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1230.336+1.787
TTM1.3750.334+1.041
YOY0.5980.269+0.329
5Y1.2690.366+0.903
10Y1.6510.390+1.261
1.4.2. Debt to Equity Ratio

Measures if OUTLOOK THERAPEUTICS INC is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare OUTLOOK THERAPEUTICS INC to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of OUTLOOK THERAPEUTICS INC:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.038-1.038
TTM1.038YOY1.762-0.724
TTM1.0385Y1.313-0.275
5Y1.31310Y1.220+0.093
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.382-0.382
TTM1.0380.396+0.642
YOY1.7620.335+1.427
5Y1.3130.434+0.879
10Y1.2200.465+0.755

2. Market Valuation of OUTLOOK THERAPEUTICS INC

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings OUTLOOK THERAPEUTICS INC generates.

  • Above 15 is considered overpriced but always compare OUTLOOK THERAPEUTICS INC to the Biotechnology industry mean.
  • A PE ratio of -0.19 means the investor is paying $-0.19 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of OUTLOOK THERAPEUTICS INC:

  • The EOD is -3.944. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.190. Based on the earnings, the company is expensive. -2
  • The TTM is -0.405. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.944MRQ-0.190-3.754
MRQ-0.190TTM-0.405+0.215
TTM-0.405YOY-3.244+2.839
TTM-0.4055Y-3.143+2.738
5Y-3.14310Y-1.859-1.285
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.944-2.259-1.685
MRQ-0.190-2.569+2.379
TTM-0.405-2.664+2.259
YOY-3.244-4.120+0.876
5Y-3.143-6.258+3.115
10Y-1.859-6.171+4.312
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of OUTLOOK THERAPEUTICS INC:

  • The EOD is -3.383. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.163. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.423. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.383MRQ-0.163-3.220
MRQ-0.163TTM-0.423+0.260
TTM-0.423YOY-4.108+3.685
TTM-0.4235Y-3.340+2.917
5Y-3.34010Y1.380-4.720
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.383-2.924-0.459
MRQ-0.163-3.246+3.083
TTM-0.423-3.488+3.065
YOY-4.108-5.620+1.512
5Y-3.340-8.315+4.975
10Y1.380-8.826+10.206
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of OUTLOOK THERAPEUTICS INC is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.35 means the investor is paying $-0.35 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of OUTLOOK THERAPEUTICS INC:

  • The EOD is -7.244. Based on the equity, the company is expensive. -2
  • The MRQ is -0.349. Based on the equity, the company is expensive. -2
  • The TTM is -1.315. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.244MRQ-0.349-6.895
MRQ-0.349TTM-1.315+0.966
TTM-1.315YOY13.284-14.600
TTM-1.3155Y7.671-8.986
5Y7.67110Y4.410+3.261
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.2441.851-9.095
MRQ-0.3492.090-2.439
TTM-1.3152.095-3.410
YOY13.2842.844+10.440
5Y7.6713.466+4.205
10Y4.4103.815+0.595
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of OUTLOOK THERAPEUTICS INC.

3.1. Institutions holding OUTLOOK THERAPEUTICS INC

Institutions are holding 6.878% of the shares of OUTLOOK THERAPEUTICS INC.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc3.98310.00011036628597287210.357
2023-12-31Vanguard Group Inc2.52070.000165604002773264.4139
2023-12-31Geode Capital Management, LLC1.14130.000129703461868656.7134
2023-12-31State Street Corporation1.0860.00012826493367221.3163
2023-12-31Northern Trust Corp0.52780.000113736511173149.3378
2023-12-31Morgan Stanley - Brokerage Accounts0.19380504471359467247.9014
2023-12-31Bank of New York Mellon Corp0.167043456700
2023-12-31Charles Schwab Investment Management Inc0.1363035461500
2023-12-31Scotia Capital Inc0.10920.0007284080-54359-16.0617
2023-12-31Millennium Management LLC0.10590.00012755722755720
2023-12-31Bank of America Corp0.0830216044112515108.6797
2023-12-31Barclays PLC0.0830215903188952701.0946
2023-12-31LPL Financial Corp0.07730.000120120010000098.8142
2023-12-31Rhumbline Advisers0.07450.000119383100
2023-12-31First Merchants Corp0.05730.004814917000
2023-12-31Gables Capital Management Inc0.05630.0359146500-8000-5.178
2023-12-31UBS Group AG0.048301258131258130
2023-12-31Ancora Advisors LLC0.04690.0011122000100000454.5455
2023-12-31Goldman Sachs Group Inc0.042501106684943680.7356
2023-12-31Renaissance Technologies Corp0.04050.00011054181054180
Total 10.58070.043427537027+2945913+10.7%

3.2. Funds holding OUTLOOK THERAPEUTICS INC

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv0.83630.0001361023700
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.40730.0008175839900
2024-01-31Fidelity Small Cap Index0.35880.00241548942312272.0575
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.21310.00192009600
2024-02-29Fidelity Extended Market Index0.16160.0008697507-3380-0.4822
2024-02-29Vanguard Russell 2000 ETF0.12930.0026558251448328.732
2023-12-31NT R2000 Growth Index Fund - NL0.10870.00546917800
2023-12-31NT R2000 Index Fund - NL0.10420.00254499927710.1716
2023-12-31NT R2000 Growth Index Fund - L0.08640.0053372831255847.3677
2023-12-31Northern Trust Russell 2000 Growth Index0.08640.0053372831255847.3677
2024-02-29Schwab Small Cap Index0.08210.002635461500
2023-12-31NT R2000 Index Fund - DC - NL - 20.08210.0025354373-758-0.2134
2024-02-29SPDR® Russell 2000 US Small Cap ETF0.07630.0054329264167185.349
2024-02-29iShares Russell 2000 Small-Cap Idx Instl0.06060.002526176300
2023-09-30The Vanguard Russell 2000 Growth Index0.0580.003125032600
2023-09-30BlackRock Extended Mkt Composite0.05150.000422224027141.2363
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.04670.0013201558115407133.959
2024-03-28iShares Russell 2000 ETF0.90160.0036194602960.0494
2024-02-29Fidelity Total Market Index0.04390.000118972300
2024-02-29EQ/2000 Managed Volatility IB0.04310.002518596100
Total 3.9380.049813302689+258795+1.9%

3.3. Insider Transactions

Insiders are holding 36.815% of the shares of OUTLOOK THERAPEUTICS INC.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-28Yezan Munther HaddadinBUY188211.82
2023-04-20Terry DagnonSELL2600022.8

4. Summary

4.1. Key Performance Indicators

The key performance indicators of OUTLOOK THERAPEUTICS INC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.459-0.464+1%0.118-490%-0.007-99%-0.030-94%
Book Value Per Share---1.128-0.391-65%0.257-539%-0.158-86%-0.479-58%
Current Ratio--0.4440.797-44%2.410-82%1.446-69%0.848-48%
Debt To Asset Ratio--2.1231.375+54%0.598+255%1.269+67%1.651+29%
Debt To Equity Ratio---1.038-100%1.762-100%1.313-100%1.220-100%
Dividend Per Share---0.000-100%-0%1414.426-100%1477.557-100%
Eps---0.518-0.596+15%-0.275-47%-0.306-41%-0.547+6%
Free Cash Flow Per Share---0.604-0.546-10%-0.155-74%-0.237-61%-0.312-48%
Free Cash Flow To Equity Per Share---0.604-0.486-19%0.344-275%0.004-13807%0.002-26954%
Gross Profit Margin--1.0001.0000%1.0010%1.0000%1.0000%
Intrinsic Value_10Y_max---36.692--------
Intrinsic Value_10Y_min---30.831--------
Intrinsic Value_1Y_max---1.422--------
Intrinsic Value_1Y_min---1.395--------
Intrinsic Value_3Y_max---5.991--------
Intrinsic Value_3Y_min---5.685--------
Intrinsic Value_5Y_max---12.631--------
Intrinsic Value_5Y_min---11.576--------
Market Cap176343731.000+95%8504214.20018589478.375-54%224224161.090-96%149519869.168-94%90182570.853-91%
Net Profit Margin----0%-0%-1.4080%-9.1440%
Operating Margin----0%-0%-1.2320%-9.0250%
Operating Ratio----0%-0%2.267-100%18.058-100%
Pb Ratio-7.244-1974%-0.349-1.315+277%13.284-103%7.671-105%4.410-108%
Pe Ratio-3.944-1974%-0.190-0.405+113%-3.244+1605%-3.143+1553%-1.859+877%
Price Per Share8.170+95%0.3940.861-54%1.275-69%1.614-76%1.382-71%
Price To Free Cash Flow Ratio-3.383-1974%-0.163-0.423+159%-4.108+2418%-3.340+1947%1.380-112%
Price To Total Gains Ratio-17.802-1974%-0.859-2.051+139%-13.880+1517%-8.175+852%-7.015+717%
Quick Ratio--0.2250.601-63%1.906-88%1.110-80%0.656-66%
Return On Assets---0.515-0.376-27%-0.398-23%-0.482-7%-0.535+4%
Return On Equity----0.1590%-1.1090%-0.6830%-0.7350%
Total Gains Per Share---0.459-0.464+1%0.118-490%1414.419-100%1477.527-100%
Usd Book Value---24343405.000-8449045.500-65%20135086.750-221%2261056.000-1177%-7350275.395-70%
Usd Book Value Change Per Share---0.459-0.464+1%0.118-490%-0.007-99%-0.030-94%
Usd Book Value Per Share---1.128-0.391-65%0.257-539%-0.158-86%-0.479-58%
Usd Dividend Per Share---0.000-100%-0%1414.426-100%1477.557-100%
Usd Eps---0.518-0.596+15%-0.275-47%-0.306-41%-0.547+6%
Usd Free Cash Flow---13032169.000-11776080.250-10%-13646386.750+5%-11070534.150-15%-9876772.500-24%
Usd Free Cash Flow Per Share---0.604-0.546-10%-0.155-74%-0.237-61%-0.312-48%
Usd Free Cash Flow To Equity Per Share---0.604-0.486-19%0.344-275%0.004-13807%0.002-26954%
Usd Market Cap176343731.000+95%8504214.20018589478.375-54%224224161.090-96%149519869.168-94%90182570.853-91%
Usd Price Per Share8.170+95%0.3940.861-54%1.275-69%1.614-76%1.382-71%
Usd Profit---11178239.000-12874500.000+15%-18306755.000+64%-12618663.650+13%-11723979.553+5%
Usd Revenue----0%-0%646596.100-100%1003905.579-100%
Usd Total Gains Per Share---0.459-0.464+1%0.118-490%1414.419-100%1477.527-100%
 EOD+6 -2MRQTTM+10 -20YOY+6 -235Y+6 -2710Y+10 -23

4.2. Fundamental Score

Let's check the fundamental score of OUTLOOK THERAPEUTICS INC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.944
Price to Book Ratio (EOD)Between0-1-7.244
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.225
Current Ratio (MRQ)Greater than10.444
Debt to Asset Ratio (MRQ)Less than12.123
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.515
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of OUTLOOK THERAPEUTICS INC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.082
Ma 20Greater thanMa 509.139
Ma 50Greater thanMa 1008.532
Ma 100Greater thanMa 2008.369
OpenGreater thanClose8.280
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets21,685
Total Liabilities46,028
Total Stockholder Equity-24,343
 As reported
Total Liabilities 46,028
Total Stockholder Equity+ -24,343
Total Assets = 21,685

Assets

Total Assets21,685
Total Current Assets20,389
Long-term Assets1,296
Total Current Assets
Cash And Cash Equivalents 10,357
Other Current Assets 10,033
Total Current Assets  (as reported)20,389
Total Current Assets  (calculated)20,389
+/-0
Long-term Assets
Property Plant Equipment 15
Long Term Investments 796
Long-term Assets Other 484
Long-term Assets  (as reported)1,296
Long-term Assets  (calculated)1,296
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities45,969
Long-term Liabilities60
Total Stockholder Equity-24,343
Total Current Liabilities
Short-term Debt 36,545
Short Long Term Debt 36,544
Accounts payable 3,480
Other Current Liabilities -1,856,623,057
Total Current Liabilities  (as reported)45,969
Total Current Liabilities  (calculated)-1,856,546,487
+/- 1,856,592,456
Long-term Liabilities
Capital Lease Obligations 1
Long-term Liabilities  (as reported)60
Long-term Liabilities  (calculated)1
+/- 58
Total Stockholder Equity
Common Stock2,603
Retained Earnings -479,096
Other Stockholders Equity 452,150
Total Stockholder Equity (as reported)-24,343
Total Stockholder Equity (calculated)-24,343
+/-0
Other
Capital Stock2,603
Cash and Short Term Investments 10,357
Common Stock Shares Outstanding 13,013
Current Deferred Revenue1,856,629,000
Liabilities and Stockholders Equity 21,685
Net Debt 26,188
Net Invested Capital 12,201
Net Working Capital -25,580
Property Plant and Equipment Gross 15
Short Long Term Debt Total 36,545



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-30
> Total Assets 
11,604
0
0
0
11,604
33,798
24,831
32,992
23,706
20,446
17,460
17,127
20,734
32,277
27,787
34,086
22,283
18,710
17,172
33,214
17,135
10,423
13,170
30,243
19,733
12,518
45,112
32,882
22,811
78,678
67,686
38,588
28,528
62,688
54,024
44,447
32,301
21,685
21,68532,30144,44754,02462,68828,52838,58867,68678,67822,81132,88245,11212,51819,73330,24313,17010,42317,13533,21417,17218,71022,28334,08627,78732,27720,73417,12717,46020,44623,70632,99224,83133,79811,60400011,604
   > Total Current Assets 
3,147
0
0
0
3,147
13,200
4,103
14,862
5,678
3,175
855
1,188
3,905
15,350
6,918
13,132
3,302
2,306
2,130
18,810
13,502
6,541
9,486
28,235
17,944
11,031
37,169
31,897
21,508
77,467
66,547
37,513
27,520
61,676
53,052
43,018
30,979
20,389
20,38930,97943,01853,05261,67627,52037,51366,54777,46721,50831,89737,16911,03117,94428,2359,4866,54113,50218,8102,1302,3063,30213,1326,91815,3503,9051,1888553,1755,67814,8624,10313,2003,1470003,147
       Cash And Cash Equivalents 
2,350
0
0
0
2,349
10,807
2,842
13,555
2,352
2,079
81
140
3,186
13,838
5,936
11,797
1,717
228
155
14,027
8,016
1,334
4,653
23,953
12,536
5,568
37,169
19,692
14,477
70,151
58,424
26,021
17,397
52,341
43,629
33,709
23,392
10,357
10,35723,39233,70943,62952,34117,39726,02158,42470,15114,47719,69237,1695,56812,53623,9534,6531,3348,01614,0271552281,71711,7975,93613,8383,186140812,0792,35213,5552,84210,8072,3490002,350
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
465
0
0
0
0
0
0
0
0
0
0
0000000000465000000000000000000000000000
       Net Receivables 
0
0
0
0
4,300
742
548
47
0
0
0
0
400
0
0
0
0
0
0
0
1,200
0
0
0
800
0
0
0
100
0
0
0
0
0
0
0
0
0
0000000001000008000001,20000000004000000475487424,3000000
       Other Current Assets 
797
0
0
0
797
1,651
713
1,259
3,327
1,096
774
1,048
719
1,512
982
1,336
1,585
2,078
1,975
4,783
5,486
5,207
4,833
4,282
5,408
5,463
6,624
12,205
7,031
7,316
8,123
11,492
10,124
9,335
9,423,025,000
9,309
7,587
10,033
10,0337,5879,3099,423,025,0009,33510,12411,4928,1237,3167,03112,2056,6245,4635,4084,2824,8335,2075,4864,7831,9752,0781,5851,3369821,5127191,0487741,0963,3271,2597131,651797000797
   > Long-term Assets 
0
0
0
0
8,457
20,597
20,728
18,131
18,027
17,272
16,606
15,939
16,829
16,927
20,869
20,954
18,981
16,404
15,042
14,405
3,633
3,882
3,684
2,008
1,789
1,487
7,943
985
1,303
1,211
1,139
1,074
1,007
1,012
972
1,429
1,321
1,296
1,2961,3211,4299721,0121,0071,0741,1391,2111,3039857,9431,4871,7892,0083,6843,8823,63314,40515,04216,40418,98120,95420,86916,92716,82915,93916,60617,27218,02718,13120,72820,5978,4570000
       Property Plant Equipment 
8,010
0
0
0
8,010
17,504
17,358
17,054
16,959
16,441
15,786
15,138
16,089
16,306
20,177
20,284
18,490
15,942
14,602
13,921
3,176
3,319
3,143
574
494
413
245
326
275
224
173
122
70
60
49
37
26
15
1526374960701221732242753262454134945743,1433,3193,17613,92114,60215,94218,49020,28420,17716,30616,08915,13815,78616,44116,95917,05417,35817,5048,0100008,010
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
465
854
830
824
812
805
826
809
802
794
796
796794802809826805812824830854465000000000000000000000000000
       Long-term Assets Other 
0
0
0
0
448
3,093
3,370
1,076
1,069
831
819
801
740
621
692
669
491
462
440
483
457
563
541
1,433
1,294
1,074
7,698
194
175
157
142
140
132
126
114
589
501
484
4845015891141261321401421571751947,6981,0741,2941,4335415634574834404624916696926217408018198311,0691,0763,3703,0934480000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
2,272
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000002,272000000
> Total Liabilities 
32,051
0
0
0
35,152
45,821
45,300
31,429
28,906
42,278
44,314
46,069
51,460
40,175
43,057
43,351
43,094
40,179
45,258
34,572
27,905
41,355
33,695
19,278
16,906
22,993
24,461
20,133
18,204
29,855
31,724
18,506
19,791
46,929
43,536
49,950
46,738
46,028
46,02846,73849,95043,53646,92919,79118,50631,72429,85518,20420,13324,46122,99316,90619,27833,69541,35527,90534,57245,25840,17943,09443,35143,05740,17551,46046,06944,31442,27828,90631,42945,30045,82135,15200032,051
   > Total Current Liabilities 
20,210
0
0
0
20,210
35,763
35,975
22,937
20,437
32,129
34,778
39,268
28,738
31,201
31,752
32,263
32,042
27,536
26,992
23,218
20,290
20,100
23,706
18,454
15,889
12,123
23,898
19,639
6,752
19,949
31,411
18,430
19,730
15,082
43,528
49,930
46,732
45,969
45,96946,73249,93043,52815,08219,73018,43031,41119,9496,75219,63923,89812,12315,88918,45423,70620,10020,29023,21826,99227,53632,04232,26331,75231,20128,73839,26834,77832,12920,43722,93735,97535,76320,21000020,210
       Short-term Debt 
11,350
0
0
0
11,483
11,757
11,321
6,302
6,176
10,671
12,138
16,786
5,006
17,031
18,078
18,233
18,774
14,445
12,903
11,566
11,530
11,070
15,016
8,212
7,851
594
11,212
11,619
974
12,783
22,845
10,512
10,954
28
31,837
34,740
35,555
36,545
36,54535,55534,74031,8372810,95410,51222,84512,78397411,61911,2125947,8518,21215,01611,07011,53011,56612,90314,44518,77418,23318,07817,0315,00616,78612,13810,6716,1766,30211,32111,75711,48300011,350
       Short Long Term Debt 
11,350
0
0
0
14,957
0
0
0
5,199
0
0
0
4,665
16,923
17,223
17,538
17,858
13,727
12,283
11,360
11,338
10,727
10,848
4,035
3,663
426
11,185
11,549
904
12,716
22,781
10,459
10,915
0
31,823
34,733
35,551
36,544
36,54435,55134,73331,823010,91510,45922,78112,71690411,54911,1854263,6634,03510,84810,72711,33811,36012,28313,72717,85817,53817,22316,9234,6650005,19900014,95700011,350
       Accounts payable 
3,101
0
0
0
3,101
11,617
14,416
4,534
5,072
11,049
12,153
11,792
10,954
3,630
3,608
3,351
3,610
4,696
5,113
2,988
2,278
2,568
3,307
5,009
2,395
3,334
6,332
2,672
2,196
2,546
4,160
2,481
3,491
4,170
3,620
5,055
6,575
3,480
3,4806,5755,0553,6204,1703,4912,4814,1602,5462,1962,6726,3323,3342,3955,0093,3072,5682,2782,9885,1134,6963,6103,3513,6083,63010,95411,79212,15311,0495,0724,53414,41611,6173,1010003,101
       Other Current Liabilities 
4,061
0
0
0
4,125
10,410
8,259
10,121
7,977
9,197
9,274
9,477
9,690
7,791
7,390
8,472
7,920
6,002
6,641
6,329
6,675
6,805
9,551
9,410
9,831
8,789
4,497
3,492
2,561
17,270
2,550
3,581
5,285
10,884
8,071
10,134
-1,856,624,398
-1,856,623,057
-1,856,623,057-1,856,624,39810,1348,07110,8845,2853,5812,55017,2702,5613,4924,4978,7899,8319,4109,5516,8056,6756,3296,6416,0027,9208,4727,3907,7919,6909,4779,2749,1977,97710,1218,25910,4104,1250004,061
   > Long-term Liabilities 
0
0
0
0
14,942
10,058
9,325
8,492
8,469
10,149
9,536
6,801
22,723
8,973
11,305
11,087
11,052
12,643
18,266
11,354
7,615
21,255
9,989
824
1,017
10,870
563
494
11,452
9,906
312
76
61
31,847
8
20
6
60
60620831,84761763129,90611,45249456310,8701,0178249,98921,2557,61511,35418,26612,64311,05211,08711,3058,97322,7236,8019,53610,1498,4698,4929,32510,05814,9420000
       Long term Debt Total 
0
0
0
0
0
0
3,357
2,935
2,555
304
221
200
13,411
186
3,639
3,619
3,552
3,487
3,464
3,410
3,416
11,609
9,840
545
904
10,658
129
0
10,886
9,604
0
0
0
31,820
0
0
0
0
000031,8200009,60410,886012910,6589045459,84011,6093,4163,4103,4643,4873,5523,6193,63918613,4112002213042,5552,9353,357000000
       Capital Lease Obligations 
0
0
0
0
0
0
810
565
321
113
43
35
28
42
3,511
3,507
3,453
3,400
3,607
3,552
3,558
3,829
3,671
4,275
4,231
204
56
129
112
95
78
60
43
29
14
7
4
1
147142943607895112129562044,2314,2753,6713,8293,5583,5523,6073,4003,4533,5073,51142283543113321565810000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
2,272
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000002,272000000
       Warrants
0
0
0
0
0
0
17,397
0
0
0
0
0
5,849
17,190
18,295
3,935
9,469
9,770
10,078
10,395
10,719
11,051
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000011,05110,71910,39510,0789,7709,4693,93518,29517,1905,8490000017,397000000
       Long-term Liabilities Other 
0
0
0
0
0
0
591
676
761
4,994
4,768
2,357
4,845
2,559
2,347
2,358
4,742
3,398
3,286
3,983
3,943
3,924
9,963
279
113
212
434
494
566
302
312
76
61
28
8
20
0
0
002082861763123025664944342121132799,9633,9243,9433,9833,2863,3984,7422,3582,3472,5594,8452,3574,7684,994761676591000000
       Deferred Long Term Liability 
0
0
0
0
961
0
5,376
4,881
5,153
4,850
4,547
4,244
4,467
6,228
5,319
5,110
2,758
5,758
6,476
3,961
0
0
0
0
0
0
0
0
0
144
129
128
119
114
0
0
0
0
00001141191281291440000000003,9616,4765,7582,7585,1105,3196,2284,4674,2444,5474,8505,1534,8815,37609610000
> Total Stockholder Equity
-45,151
0
0
0
-23,548
-12,023
-20,468
1,563
-5,200
-21,832
-26,854
-28,942
-30,727
-7,898
-15,270
-9,265
-20,811
-21,469
-28,086
-1,358
-10,770
-30,932
-20,525
10,965
2,826
-10,475
20,651
12,749
4,607
48,823
35,963
20,082
8,737
15,759
10,488
-5,503
-14,438
-24,343
-24,343-14,438-5,50310,48815,7598,73720,08235,96348,8234,60712,74920,651-10,4752,82610,965-20,525-30,932-10,770-1,358-28,086-21,469-20,811-9,265-15,270-7,898-30,727-28,942-26,854-21,832-5,2001,563-20,468-12,023-23,548000-45,151
   Common Stock
0
0
0
0
39,845
161
124
228
228
236
241
247
249
255
257
722
722
851
118
282
286
384
898
1,264
1,272
1,272
1,736
1,748
1,765
2,243
2,258
2,259
2,273
2,567
2,567
2,587
2,603
2,603
2,6032,6032,5872,5672,5672,2732,2592,2582,2431,7651,7481,7361,2721,2721,26489838428628211885172272225725524924724123622822812416139,8450000
   Retained Earnings -479,096-467,918-454,927-434,252-427,598-408,936-394,590-377,051-357,346-342,883-329,479-317,282-304,176-289,720-279,798-276,783-271,083-254,480-244,384-239,943-229,698-216,307-204,108-195,676-188,136-186,215-179,864-174,537-166,492-147,394-136,798-114,471-110,928-45,151000-45,151
   Capital Surplus 
0
0
0
0
0
0
76,482
138,133
141,965
144,425
147,442
150,676
152,315
160,130
159,191
190,186
190,040
202,493
211,740
237,546
238,065
239,767
255,361
289,500
291,274
292,429
336,197
340,480
345,726
403,927
410,755
412,413
415,399
440,790
442,173
446,838
0
0
00446,838442,173440,790415,399412,413410,755403,927345,726340,480336,197292,429291,274289,500255,361239,767238,065237,546211,740202,493190,040190,186159,191160,130152,315150,676147,442144,425141,965138,13376,482000000
   Treasury Stock00000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
14,044
102,913
98,638
-32,992,181,508
147,927
151,056
154,745
158,651
160,960
169,452
169,244
201,061
201,740
214,977
220,001
251,680
239,116
234,881
256,065
-30,242,669,801
292,014
-12,517,689,790
336,197
340,480
345,726
403,927
-2,258
-2,259
-2,273
-62,688,432,566
-54,024,030,566
446,837
450,878
452,150
452,150450,878446,837-54,024,030,566-62,688,432,566-2,273-2,259-2,258403,927345,726340,480336,197-12,517,689,790292,014-30,242,669,801256,065234,881239,116251,680220,001214,977201,740201,061169,244169,452160,960158,651154,745151,056147,927-32,992,181,50898,638102,91314,0440000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-44
Gross Profit-44-44
 
Operating Income (+$)
Gross Profit-44
Operating Expense-53,126
Operating Income-53,126-53,170
 
Operating Expense (+$)
Research Development26,453
Selling General Administrative26,673
Selling And Marketing Expenses0
Operating Expense53,12653,126
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,560
Other Finance Cost-0
Net Interest Income-1,560
 
Pretax Income (+$)
Operating Income-53,126
Net Interest Income-1,560
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-58,980-48,832
EBIT - interestExpense = -54,203
-58,980
-57,423
Interest Expense1,560
Earnings Before Interest and Taxes (EBIT)-52,643-57,420
Earnings Before Interest and Taxes (EBITDA)-52,599
 
After tax Income (+$)
Income Before Tax-58,980
Tax Provision-3
Net Income From Continuing Ops-58,983-58,983
Net Income-58,983
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses53,126
Total Other Income/Expenses Net-4,2941,560
 

Technical Analysis of OUTLOOK THERAPEUTICS INC
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of OUTLOOK THERAPEUTICS INC. The general trend of OUTLOOK THERAPEUTICS INC is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine OUTLOOK THERAPEUTICS INC's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of OUTLOOK THERAPEUTICS INC.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.85 < 13.20 < 13.32.

The bearish price targets are: 6.8 > 5.172 > 5.0401.

Tweet this
OUTLOOK THERAPEUTICS INC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of OUTLOOK THERAPEUTICS INC. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

OUTLOOK THERAPEUTICS INC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of OUTLOOK THERAPEUTICS INC. The current macd is 0.01265768.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the OUTLOOK THERAPEUTICS INC price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for OUTLOOK THERAPEUTICS INC. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the OUTLOOK THERAPEUTICS INC price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
OUTLOOK THERAPEUTICS INC Daily Moving Average Convergence/Divergence (MACD) ChartOUTLOOK THERAPEUTICS INC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of OUTLOOK THERAPEUTICS INC. The current adx is 29.55.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy OUTLOOK THERAPEUTICS INC shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
OUTLOOK THERAPEUTICS INC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of OUTLOOK THERAPEUTICS INC. The current sar is 11.88.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
OUTLOOK THERAPEUTICS INC Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of OUTLOOK THERAPEUTICS INC. The current rsi is 45.08. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
OUTLOOK THERAPEUTICS INC Daily Relative Strength Index (RSI) ChartOUTLOOK THERAPEUTICS INC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of OUTLOOK THERAPEUTICS INC. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the OUTLOOK THERAPEUTICS INC price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
OUTLOOK THERAPEUTICS INC Daily Stochastic Oscillator ChartOUTLOOK THERAPEUTICS INC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of OUTLOOK THERAPEUTICS INC. The current cci is -112.61324893.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
OUTLOOK THERAPEUTICS INC Daily Commodity Channel Index (CCI) ChartOUTLOOK THERAPEUTICS INC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of OUTLOOK THERAPEUTICS INC. The current cmo is -21.18910222.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
OUTLOOK THERAPEUTICS INC Daily Chande Momentum Oscillator (CMO) ChartOUTLOOK THERAPEUTICS INC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of OUTLOOK THERAPEUTICS INC. The current willr is -94.23728814.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
OUTLOOK THERAPEUTICS INC Daily Williams %R ChartOUTLOOK THERAPEUTICS INC Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of OUTLOOK THERAPEUTICS INC.

OUTLOOK THERAPEUTICS INC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of OUTLOOK THERAPEUTICS INC. The current atr is 1.03118817.

OUTLOOK THERAPEUTICS INC Daily Average True Range (ATR) ChartOUTLOOK THERAPEUTICS INC Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of OUTLOOK THERAPEUTICS INC. The current obv is 19,092,780.

OUTLOOK THERAPEUTICS INC Daily On-Balance Volume (OBV) ChartOUTLOOK THERAPEUTICS INC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of OUTLOOK THERAPEUTICS INC. The current mfi is 21.61.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
OUTLOOK THERAPEUTICS INC Daily Money Flow Index (MFI) ChartOUTLOOK THERAPEUTICS INC Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for OUTLOOK THERAPEUTICS INC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

OUTLOOK THERAPEUTICS INC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of OUTLOOK THERAPEUTICS INC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.082
Ma 20Greater thanMa 509.139
Ma 50Greater thanMa 1008.532
Ma 100Greater thanMa 2008.369
OpenGreater thanClose8.280
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of OUTLOOK THERAPEUTICS INC with someone you think should read this too:
  • Are you bullish or bearish on OUTLOOK THERAPEUTICS INC? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about OUTLOOK THERAPEUTICS INC? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about OUTLOOK THERAPEUTICS INC

I send you an email if I find something interesting about OUTLOOK THERAPEUTICS INC.


Comments

How you think about this?

Leave a comment

Stay informed about OUTLOOK THERAPEUTICS INC.

Receive notifications about OUTLOOK THERAPEUTICS INC in your mailbox!